Log in to save to my catalogue

Nanotechnology for the Treatment of Allergic Conjunctival Diseases

Nanotechnology for the Treatment of Allergic Conjunctival Diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_262dd712377c49fa958ed9c2a3c2c008

Nanotechnology for the Treatment of Allergic Conjunctival Diseases

About this item

Full title

Nanotechnology for the Treatment of Allergic Conjunctival Diseases

Publisher

Switzerland: MDPI

Journal title

Pharmaceuticals (Basel, Switzerland), 2020-10, Vol.13 (11), p.351

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

More information

Scope and Contents

Contents

Allergic conjunctivitis is one of the most common external eye diseases and the prevalence has been increasing. The mainstay of treatment is topical eye drops. However, low bioavailability, low ocular drug penetration, transient resident time on the ocular surface due to tear turnover, frequent topical applications and dependence on patient complia...

Alternative Titles

Full title

Nanotechnology for the Treatment of Allergic Conjunctival Diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_262dd712377c49fa958ed9c2a3c2c008

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_262dd712377c49fa958ed9c2a3c2c008

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph13110351

How to access this item